Genome-wide sequencing to identify the cause of hereditary cancer syndromes: with examples from familial pancreatic cancer.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Cancer Letters

• Publication date

  2013-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.canlet.2012.11.008PMID 23196058PMCID PMC3652916
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Targeted Capture and Massively Parallel Sequencing of Twelve Human Exomes

  2016cited by this paper
• Predisposition gene identification in common cancers by exome sequencing: insights from familial breast cancer

  2012cited by this paper
• Comprehensive molecular characterization of human colon and rectal cancer

  2012cited by this paper
• Genetics and pathogenesis of chronic pancreatitis: the 2012 update.

  2012cited by this paper
• Genetic susceptibility to pancreatic cancer

  2012cited by this paper
• Rare mutations in XRCC2 increase the risk of breast cancer.

  2012cited by this paper
• Identifying and exploiting defects in the Fanconi anemia/BRCA pathway in oncology.

  2012cited by this paper
• Hereditary mixed polyposis syndrome is caused by a 40kb upstream duplication that leads to increased and ectopic expression of the BMP antagonist GREM1

  2012cited by this paper
• ATM mutations in patients with hereditary pancreatic cancer.

  2012influential reference
• Risk of cancer other than breast or ovarian in individuals with BRCA1 and BRCA2 mutations

  2011cited by this paper
• Inherited colorectal cancer syndromes.

  2011cited by this paper
• Identification of functional genetic variation in exome sequence analysis

  2011cited by this paper
• BRCA1 and BRCA2: different roles in a common pathway of genome protection

  2011cited by this paper
• Inherited Mutations in Breast Cancer Genes—Risk and Response

  2011cited by this paper
• Juvenile polyposis syndrome.

  2011cited by this paper
• Contribution of inherited mutations in the BRCA2-interacting protein PALB2 to familial breast cancer.

  2011cited by this paper
• Genetic architecture of cancer and other complex diseases: lessons learned and future directions.

  2011cited by this paper
• Whole-Genome Sequencing of a Single Proband Together with Linkage Analysis Identifies a Mendelian Disease Gene

  2010cited by this paper
• Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial.

  2010cited by this paper
• A method and server for predicting damaging missense mutations

  2010cited by this paper
• Poly(ADP)-ribose polymerase inhibition: frequent durable responses in BRCA carrier ovarian cancer correlating with platinum-free interval.

  2010cited by this paper
• Update on familial pancreatic cancer.

  2010cited by this paper
• Integrating common and rare genetic variation in diverse human populations

  2010cited by this paper
• A map of human genome variation from population-scale sequencing

  2010cited by this paper
• Peutz–Jeghers syndrome: a systematic review and recommendations for management

  2010cited by this paper
• Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial.

  2010cited by this paper
• PALB2 mutations in European familial pancreatic cancer families

  2010cited by this paper
• Analysis of next-generation genomic data in cancer: accomplishments and challenges.

  2010cited by this paper
• Exome sequencing identifies MLL2 mutations as a cause of Kabuki syndrome

  2010cited by this paper
• The Human Gene Mutation Database: 2008 update

  2009cited by this paper
• A Groupwise Association Test for Rare Mutations Using a Weighted Sum Statistic

  2009cited by this paper
• Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers.

  2009cited by this paper
• Exomic Sequencing Identifies PALB2 as a Pancreatic Cancer Susceptibility Gene

  2009cited by this paper
• Targeted Capture and Massively Parallel Sequencing of Twelve Human Exomes

  2009cited by this paper
• Review of the Lynch syndrome: history, molecular genetics, screening, differential diagnosis, and medicolegal ramifications

  2009cited by this paper
• Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm

  2009cited by this paper
• Familial Atypical Multiple Mole Melanoma Syndrome

  2009cited by this paper
• Exome sequencing identifies the cause of a Mendelian disorder

  2009cited by this paper
• Familial pancreatic cancer.

  2009cited by this paper
• Analysis of the gene coding for the BRCA2-interacting protein PALB2 in familial and sporadic pancreatic cancer.

  2009cited by this paper
• Risk of pancreatic cancer in families with Lynch syndrome.

  2009cited by this paper
• Absence of germline BRCA1 mutations in familial pancreatic cancer patients

  2009cited by this paper
• BRCA germline mutations in Jewish patients with pancreatic adenocarcinoma.

  2009cited by this paper
• Genetic diagnosis by whole exome capture and massively parallel DNA sequencing

  2009cited by this paper
• Ataxia-telangiectasia: from a rare disorder to a paradigm for cell signalling and cancer

  2008cited by this paper
• Ataxia-telangiectasia: from a rare disorder to a paradigm for cell signalling and cancer

  2008cited by this paper
• Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses

  2008cited by this paper
• Bone morphogenetic protein signalling in colorectal cancer

  2008cited by this paper
• The clinical management of BRCA1 and BRCA2 mutation carriers

  2008cited by this paper
• The Prevalence of BRCA2 Mutations in Familial Pancreatic Cancer

  2007cited by this paper
• Meta-analysis of BRCA1 and BRCA2 penetrance.

  2007cited by this paper
• The role of ATM in breast cancer development

  2007cited by this paper
• PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene

  2007cited by this paper
• A strategy to discover genes that carry multi-allelic or mono-allelic risk for common diseases: a cohort allelic sums test (CAST).

  2007cited by this paper
• The Genomic Landscapes of Human Breast and Colorectal Cancers

  2007cited by this paper
• Frequency and Spectrum of Cancers in the Peutz-Jeghers Syndrome

  2006cited by this paper
• Clinical management of BRCA1 and BRCA2 mutation carriers

  2006cited by this paper
• Familial Adenomatous Polyposis

  2006cited by this paper
• The Consensus Coding Sequences of Human Breast and Colorectal Cancers

  2006cited by this paper
• High-risk melanoma susceptibility genes and pancreatic cancer, neural system tumors, and uveal melanoma across GenoMEL.

  2006cited by this paper
• Clinical management of BRCA1 and BRCA2 mutation carriers

  2006cited by this paper
• Mutations in embryonic myosin heavy chain (MYH3) cause Freeman-Sheldon syndrome and Sheldon-Hall syndrome

  2006cited by this paper
• Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy

  2005cited by this paper
• Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase

  2005cited by this paper
• Distribution and intensity of constraint in mammalian genomic sequence.

  2005cited by this paper
• Molecular pathology of ataxia telangiectasia

  2005cited by this paper
• Role of BRCA1 and BRCA2 as regulators of DNA repair, transcription, and cell cycle in response to DNA damage

  2004cited by this paper
• Cancer as a Complex Phenotype: Pattern of Cancer Distribution within and beyond the Nuclear Family

  2004cited by this paper
• Prospective Risk of Pancreatic Cancer in Familial Pancreatic Cancer Kindreds

  2004cited by this paper
• Cancer Incidence in BRCA1 mutation carriers.

  2002cited by this paper
• Evaluation of candidate genes MAP2K4, MADH4, ACVR1B, and BRCA2 in familial pancreatic cancer: deleterious BRCA2 mutations in 17%.

  2002cited by this paper
• Evidence for a major gene influencing risk of pancreatic cancer

  2002cited by this paper
• Cancer risk in heterozygotes for ataxia‐telangiectasia

  2001cited by this paper
• Estimating the world cancer burden: Globocan 2000

  2001cited by this paper
• Very high risk of cancer in familial Peutz-Jeghers syndrome.

  2000cited by this paper
• Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland.

  2000cited by this paper
• Cancer risks in BRCA2 mutation carriers.

  1999cited by this paper
• Link between breast cancer and ATM gene is strong

  1999cited by this paper
• Heterozygous ATM mutations do not contribute to early onset of breast cancer

  1997cited by this paper
• Hereditary pancreatitis and the risk of pancreatic cancer. International Hereditary Pancreatitis Study Group.

  1997cited by this paper
• Molecular genotyping shows that ataxia-telangiectasia heterozygotes are predisposed to breast cancer.

  1996cited by this paper
• Increased risk of pancreatic cancer in melanoma-prone kindreds with p16INK4 mutations.

  1995cited by this paper
• Family history and the risk of liver, gallbladder, and pancreatic cancer.

  1994cited by this paper
• Increased risk of thyroid and pancreatic carcinoma in familial adenomatous polyposis.

  1993cited by this paper
• Breast and other cancers in families with ataxia-telangiectasia.

  1987cited by this paper
• Pancreatic cancer in father and son.

  1977cited by this paper
• Familial carcinoma of the pancreas *

  1976cited by this paper
• Malignant neoplasms in the families of patients with ataxia-telangiectasia.

  1976cited by this paper
• Adenocarcinoma of the pancreas in four siblings.

  1973cited by this paper
• ALLERGIC REACTIONS TO BITING INSECTS

  1972cited by this paper
• Heredity and malignant melanoma: implications for early cancer detection.

  1968cited by this paper

• Retrotransposons and the brain: Exploring a complex relationship between mobile elements, stress, and neurological health

  2025cites this paper
• Deciphering Genetic Alterations of Taiwanese Patients with Pancreatic Adenocarcinoma through Targeted Sequencing

  2022cites this paper
• Clinical Perspective on Proteomic and Glycomic Biomarkers for Diagnosis, Prognosis, and Prediction of Pancreatic Cancer

  2021cites this paper
• Deciphering Genetic Alterations of Taiwanese Pancreatic Adenocarcinoma With Targeted Sequencing

  2021cites this paper
• Deleterious Germline Mutations Are a Risk Factor for Neoplastic Progression Among High-Risk Individuals Undergoing Pancreatic Surveillance.

  2019cites this paper
• New Hope for Pancreatic Ductal Adenocarcinoma Treatment Targeting Endoplasmic Reticulum Stress Response: A Systematic Review

  2018cites this paper
• Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine 1454 Analysis of inherited and somatic variants to decipher canine complex traits

  2018cites this paper
• Pancreatitis-Associated Genes and Pancreatic Cancer Risk

  2018cites this paper
• Hereditary pancreatic cancer: related syndromes and clinical perspective

  2017cites this paper
• Alterations of type II classical cadherin, cadherin‐10 (CDH10), is associated with pancreatic ductal adenocarcinomas

  2017cites this paper
• Challenges and Perspectives of the Risk Assessment of the Genetic Susceptibility to Cancer in the Next-Generation Sequencing Era

  2017cites this paper
• Non-coding regulatory variations: the dark matter of pancreatic cancer genomics

  2017cites this paper
• New Developments in the Molecular Mechanisms of Pancreatic Tumorigenesis.

  2017cites this paper
• Discrimination of CD44 and Oct3/4 Expression in Pancreatic Adenocarcinoma from Benign Pancreatic Ducts in Small Biopsy Specimens.

  2017cites this paper
• Association between vitamin A, retinol and carotenoid intake and pancreatic cancer risk: Evidence from epidemiologic studies

  2016cites this paper
• The detection of tumor location and lymph node metastasis by aberrant NXPH1 and NXPH2 expressions in pancreatic ductal adenocarcinomas.

  2016cites this paper
• Hereditary cancer risk assessment: insights and perspectives for the Next-Generation Sequencing era

  2016cites this paper
• GOT1/AST1 expression status as a prognostic biomarker in pancreatic ductal adenocarcinoma

  2015cites this paper
• Hereditary Pancreatic Cancer Syndromes.

  2015cites this paper
• Pancreatic cancer: current understanding of molecular and genetic aetiologies

  2015cites this paper
• Pancreatic tumors: an overview

  2014cites this paper
• Atlas of Genetics and Cytogenetics in Oncology and Haematology Pancreatic tumors : an overview

  2014cites this paper
• Clinical massively parallel next-generation sequencing analysis of 409 cancer-related genes for mutations and copy number variations in solid tumours

  2014cites this paper